Immunocore Holdings plc (FRA:6YG)

Germany · Delayed Price · Currency is EUR

27.60

-0.40 (-1.43%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Immunotherapies	310.20M	249.43M	174.36M	36.48M	41.11M
Immunotherapies Growth	24.37%	43.05%	377.91%	-11.26%	20.94%
Total	310.20M	249.43M	174.36M	36.48M	41.11M
Total Growth	24.37%	43.05%	377.91%	-11.26%	20.94%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	226.69M	169.79M	96.89M	-	-
United States Growth	33.51%	75.24%	-	-	-
Europe	73.22M	67.63M	42.75M	4.08M	-
Europe Growth	8.27%	58.21%	948.19%	-	-
International	10.08M	1.32M	1.05M	-	-
International Growth	665.81%	25.45%	-	-	-
Total	309.99M	238.74M	140.69M	4.08M	-
Total Growth	29.85%	69.69%	3349.90%	-	-

Source: S&P Global Market Intelligence.